Companies research board

Displaying 4901 - 5000 of 5884

Private equity firm.


Investor in early stage data and quantum companies.


(夏焱资本管理有限公司)
Asia-based investment company.


Early stage venture capital firm focused on select areas within the wireless, digital media, and information technology sectors


Private equity firm with a focus on growth capital


( 武岳峰资本)


(Sun Capital), (Sun European Partners)
Private investment firm focused on LBOs that is led by Co-CEOs Marc Leder and Rodger Krouse.


Early stage venture capital firm with a focus on insurance related projects.


(Sutter Rock Capital)
Publicly traded investment fund that seeks to identify and invest in rapidly growing, late stage, venture capital-backed private companies.


Early stage technology venture capital firm.


(SGE)
Private equity group investing in growth capital and buyout opportunities in financial technology, information services, and software.


The venture investment arm of the Singapore University of Technology and Design.


Private equity firm based in Palo Alto, Clifornia.


Venture capital and private equity investment syndicate investing in B2B, B2C, impact, and deep tech investments (early stage and late stage/pre-IPO).


Silicon Valley-based angel fund.


Early stage venture capital firm that invests in science + technology enabled startups to transform societies, the environment, and health.


(Dementia Discovery Fund), (DDF)


Investment management company specialized in private equity, private infrastructure and private debt.


Venture capital firm accelerating seed-stage AI and automation companies.


Investment vehicle that focuses on acquisitions, investments, and other business development within the dating and social networking industry.


The venture capital arm of Swisscom.


Global investment firm with offices in the US, India and Singapore.


The venture capital arm of Symantec, focused on investing into cyber security startups.


Institutional digital asset management and early-stage venture capital.


(兴诺资本)
Global investment firm focused on developing breakthrough innovations to meet modern healthcare challenges.


Venture firm accelerating life-changing solutions to cure, prevent, and treat type 1 diabetes (T1D) through catalytic commercial investments.